Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 3 1Phase 2 1Phase 1 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Pulmonary Disease, Chronic Obstructive 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lung Neoplasms 1Asthma 1

Interventions

Dexamethasone 49Metformin 47Cyclophosphamide 42Saline Solution 38Cytarabine 34Sodium Chloride 32Bupivacaine 31Vincristine 27Cisplatin 26Propofol 25Methotrexate 25Letrozole 24Fluorouracil 24Dexmedetomidine 24Doxorubicin 23Fentanyl 22Carboplatin 22Etoposide 19Rituximab 18Morphine 18Bevacizumab 18Acetaminophen 18Lidocaine 17Granulocyte Colony-Stimulating Factor 17Prednisone 16Mercaptopurine 16Docetaxel 16Clomiphene 16Sevoflurane 15Ropivacaine 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × OTHER × Budesonide × Clear all
NCT03369847 2019-07-18

Inhaled Steroids for Pediatric Asthma at Pediatric Emergency Medicine Discharge

New York City Health and Hospitals Corporation

Phase 4 Completed
43 enrolled
LymphoidOther hematologic neoplasm

Asthma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02504801 2015-07-22

Efficacy of Nebulized Pulmicort Respules in Primary Lung Cancer Patients With COPD

Xuanwu Hospital, Beijing

Phase 4 Unknown
73 enrolled
Thoracic

Lung Neoplasms, Pulmonary Disease, Chronic Obstructive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡